Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Eylea 40 mg/ml solution for injection in pre-filled syringe

Active Ingredient:
aflibercept
Company:  
Bayer plc See contact details
ATC code: 
S01LA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video
{arrow_left}
{arrow_right}
EYLEA WAMD Patient Guide - Audio Version

Your guide to Eylea - for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Reference: PP-EYL-GB-2763

EYLEA DMO Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to diabetic macular oedema (DMO)

Reference: PP-EYL-GB-2765

EYLEA BRVO Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO)

Reference: PP-EYL-GB-2764

EYLEA CRVO Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO)

Reference: PP-EYL-GB-2766

EYLEA CNV Patient Guide - Audio Version

Your guide to Eylea - for the treatment of visual impairment due to myopic choroidal neovascularisation(myopic CNV)

Reference: PP-EYL-GB-2762

EYLEA Prescriber Guide

Intravitreal injection procedure video intended for Healthcare Professionals

Reference: PP-EYL-GB-2586

Bayer plc
Company image
Address
400 South Oak Way, Reading, Berkshire, RG2 6AD
Medical Information e-mail
[email protected]
WWW
http://www.bayer.co.uk
Telephone
+44 (0)118 206 3000